Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'bax inhibitor peptide negative control'

Search results for: 'bax inhibitor peptide negative control'

Items 1-10 of 58

Page
per page
  1. INCB024360 analogue
    A3493 INCB024360 analogue
    Summary: potent and selective inhibitor of IDO1
      ≥13.55 mg/mL
  2. LB42708
    B3703 LB42708
    Target: Ftase
    Summary: Selective FTase inhibitor
      ≥22.75 mg/mL
  3. CP-91149
    A8403 CP-91149
    Target: Glycogen Phosphorylases
    Summary: Selective inhibitor of glycogen phosphorylase
      insoluble in H2O; ≥16.4 mg/mL
  4. Tioxolone
    A4362 Tioxolone
    Target: Carbonic Anhydrases
    Summary: CAI inhibitor
      ≥63.2 mg/mL
  5. A922500
    A4382 A922500
    Target: DGAT
    Summary: DGAT-1 inhibitor
      ≥21.25 mg/mL
  6. Vinpocetine
    B2276 Vinpocetine
    Target: Phosphodiesterases (PDEs)
    Summary: PDE inhibitor
      ≥2.59 mg/mL
  7. 17-DMAG (Alvespimycin) HCl
    A2213 17-DMAG (Alvespimycin) HCl
     1 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor
      ≥26.2 mg/mL
  8. Abiraterone acetate
    A8202 Abiraterone acetate
    Target: Cytochrome P450 (CYP450)
    Summary: Cytochrome p450 17a1 inhibitor
      insoluble in H2O; ≥11.22 mg/mL
  9. Avanafil
    A4334 Avanafil
    Target: Phosphodiesterases (PDEs)
    Summary: PDE5 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL
  10. Avasimibe
    A4318 Avasimibe
    Target: Acyl coenzyme A: cholesterol acyltransferases
    Summary: ACAT inhibitor,orally bioavailable
      ≥25.09 mg/mL

Items 1-10 of 58

Page
per page
Shop By
Now Shopping by
  1. Category Metabolism Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Aminopeptidase 1 item
  2. Carbonic Anhydrase 3item
  3. CETP 2item
  4. CYP3A/CYP450 1 item
  5. Dehydrogenase 1 item
  6. DGAT 1 item
  7. Dopamine β-hydroxylase 2item
  8. FAAH 1 item
  9. Factor Xa 1 item
  10. HMG-CoA Reductase 5item
  11. HSP 9item
  12. IDO 3item
  13. KRAS-PDEδ 1 item
  14. Lipid Metabolism 1 item
  15. P450 3item
  16. PDE 12item
  17. Phospholipase 2item
  18. SCD 1 item
  19. SGLT 1 item
  20. Transferase 6item
  21. monooxygenase 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 3item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 10item
  4. Kynurenine-3-monooxygenase 1 item
  5. Aminopeptidases 1 item
  6. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  7. HSP90 7item
  8. Cytochrome P450 (CYP450) 3item
  9. HMG-CoA Reductases 5item
  10. SGLT 1 item
  11. DGAT 2item
  12. CETP 2item
  13. Lactate Dehydrogenases (LDH) 1 item
  14. Fatty-acid-binding proteins (FABPs) 1 item
  15. Nampt 1 item
  16. Carbonic Anhydrases 3item
  17. Aldehyde Dehydrogenases 1 item
  18. Phospholipases 1 item
  19. Catechol O-Methyltransferase (COMT) 1 item
  20. FPTase 1 item
  21. Ftase 1 item
  22. FAAH 1 item
  23. IDO 1 item
  24. Glycogen Phosphorylases 1 item
Related Disease
  1. Acne 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Carcinoma 1 item
  4. Brain Injuries Studies 1 item
  5. Breast Cancer 7item
  6. Cancer 23item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Cocaine-Related Disorders 2item
  9. Colon Cancer 1 item
  10. Diabetes 2item
  11. Dyslipidemia 1 item
  12. Epilepsy 1 item
  13. Erectile Dysfunction 3item
  14. Glioblastoma 1 item
  15. Glioma 1 item
  16. Hepatic Cancer 1 item
  17. HIV Infections 1 item
  18. Hypercholesterolemia 2item
  19. Inflammation 1 item
  20. Inflammatory Diseases 1 item
  21. Leukemia 1 item
  22. Lung Cancer 3item
  23. Lymphoma 1 item
  24. Melanoma 6item
  25. Multiple Myeloma 2item
  26. Neuroblastoma 2item
  27. Neurocognitive Disorders 1 item
  28. Non-small Cell Lung Cancer 2item
  29. Obsessive-Compulsive Disorder 1 item
  30. Osteoporosis 1 item
  31. Pancreatic Cancer 2item
  32. Pancreatic Carcinoma 1 item
  33. Prostate Cancer 7item
  34. Psoriasis 2item
  35. Psoriasis Vulgaris 1 item
  36. Pulmonary Arterial Hypertension 1 item
  37. Rheumatoid Arthritis 1 item
  38. Schizophrenia 2item
  39. Type 2 Diabetes 2item